The U.S. government’s aid freeze has created major disruptions in the supply chains of medical products integral to combating diseases such as HIV and malaria in impoverished countries. Sources indicate the supply gaps may persist for months, affecting vital orders typically handled by the U.S. Agency for International Development.
About the Author
